Lead time associated with screening for prostate cancer. (Q39669271)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2004

edit

Language	Label	Description	Also known as
English	Lead time associated with screening for prostate cancer.	scientific article published on January 2004

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

title

Lead time associated with screening for prostate cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

main subject

prostate cancer screening

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author

Hans Lilja

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

Magnus Törnblom

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

author name string

Henry Eriksson

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

Stefan Franzén

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

Ove Gustafsson

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

Ulf Norming

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

Jonas Hugosson

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

language of work or name

English

0 references

publication date

1 January 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

published in

International Journal of Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

volume

108

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

page(s)

122-129

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

cites work

Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Alternative definitions of comparable case groups and estimates of lead time and benefit time in randomized cancer screening trials.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Should we start population screening for prostate cancer? Randomised trials are still needed

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Lead-time in prostate cancer screening (Finland)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

The value of prostate specific antigen in early diagnosis of prostate cancer: the study of men born in 1913

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Prostatic intraepithelial neoplasia does not appear to raise serum prostate-specific antigen concentration

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.11554

retrieved

21 January 2018

Identifiers

DOI

10.1002/IJC.11554

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

PubMed publication ID

14618626

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14618626

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

ResearchGate publication ID

9007354

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39669271&oldid=2246301251"